title: Looking at the seemingly contradictory role of vinblastine in anaplastic large-cell lymphoma from a metronomic perspective.
authors.forename: Nicolas
authors.initials: N
authors.lastname: André
authors.forename: Eddy
authors.initials: E
authors.lastname: Pasquier
authors.forename: Jean Claude
authors.initials: JC
authors.lastname: Gentet
authors.forename: Barton A
authors.initials: BA
authors.lastname: Kamen
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D006801:Humans; D017728:Lymphoma, Large-Cell, Anaplastic / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D016896:Treatment Outcome; D019139:Tumor Escape / Q000187:drug effects; D014747:Vinblastine / Q000008:administration & dosage
chemical_list: D020533:Angiogenesis Inhibitors; D014747:Vinblastine